Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1.90	83.20	81.65
Graham Fair Price	17.92	11.51	9.76
PEG	-91.54	0.69	8.15
Price/Book	1.32	1.90	1.87
Price/Cash Flow	-72.00	79.62	284.40
Prices/Earnings	-27.52	29.53	40.73
Price/Sales	-1.34	31.16	31.59
Price/FCF	-72.00	79.62	284.40
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.24	0.29	0.30
Operating Margin	-4.27	0.22	0.23
ROA	39.98	< 0.005	< 0.005
ROE	0.01	0.02	39.79
ROIC	< 0.005	< 0.005	-1.52
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.02	-62.22
Dividends QOQ	< 0.005	0.18	14736.31
EBIT QOQ	-0.62	< 0.005	98.43
EPS QOQ	0.05	0.43	757.14
FCF QOQ	-0.73	2.65	263.21
Revenue QOQ	-0.02	0.03	70.31
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	15.15	9.62	-36.50
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.39	0.39	0.11
Quick Ratio	0.58	0.81	40.78
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	19.20	19.15	-0.26
Cash	0.61	0.77	26.45
Capex	-0.23	-0.09	58.61
Free Cash Flow	0.13	0.46	260.98
Revenue	1.14	1.17	2.43
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.52	0.81	54.37
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.09	20.08	-0.03
Naive Interpretation	Member

06 - Financial Health · Bad

Rating